Sanofi has continued the breakneck pace of dealmaking activity, paying $150 million upfront to make IGM Biosciences the third partner added in a hectic month for its business development team. The ...

Dogma holds that plasma cells, as opposed to B cells, cannot bind antigen because they have switched from expression of membrane-bound immunoglobulins (Ig) that constitute the B-cell receptor (BCR) to ...

IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. Now, the company has become the latest to join a hot trend in cell therapy biotech—pivoting from oncology to ...

Natural IgM, a pentameric, polyreactive antibody, is mainly secreted by peritoneal B1 B cells and recognizes and binds self antigens such as phospholipids. The unique structure of natural IgM allows ...

IGM Biosciences announced they are halting the development of two investigational drugs for autoimmune and inflammatory diseases, imvotamab (an IgM-based CD20 X CD3 bispecific antibody T cell engager) ...

IGM Financial Inc. reported that, as of November 30, 2025, its total assets under management and advisement reached a record high of CA$311.10 billion, up 13.8% year over year, supported by CA$753.00 ...

CNW/ - IGM Financial Inc. (IGM) (TSX: IGM) today reported total assets under management and advisement reached an all-time ...

IGM has outperformed the market since October 2022, benefiting from strong earnings growth rates in the technology sector. The fund's valuation is very expensive, with subsectors like application ...

MOUNTAIN VIEW, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced ...

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies ...

The country is seeing a massive dengue outbreak as thousands of cases are being reported monthly. This is a mosquito-borne illness that begins in the monsoon(mosquito ...

Toronto-based IGM Technology, which sells financial software to local and state agencies, has gained a “strategic growth investment” from Lead Edge Capital. The amount of the investment went ...